Amedisys, Inc. (AMED) Misses Q1 EPS by 3c

Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $298.74 million versus the consensus estimate of $301.89 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Freeport-McMoRan shares surge as copper hits record $14,694/ton
• Avianca secures first of its kind financing from the Brazilian Agency for the Management of Guarantee Funds and Guarantees (ABGF) for Maintenance, Repair and Overhaul (MRO) services at GE Aerospace's